Economists estimated the worldwide legal marijuana industry to be worth $13.2 billion in 2021. The rising desire for the legalization of marijuana is a key factor in this increase. For example, and especially since the pandemic’s arrival, we’ve seen that pot shops don’t have too much to worry about regarding demand.
The biggest and fastest-growing cannabis market is in North America. The main drivers of the expansion include the legalization of cannabis, the developments in intellectual property rights, ongoing research and development initiatives for genetic modification, and the evident usefulness of cannabis in medical applications. Over two-thirds of U.S. states have made marijuana legal at this point. And, over the next five years, some experts project that the legal cannabis industry will grow much higher – no pun intended – by 28%, bringing the global industry’s overall value up to about $17 billion.
Now, join me as I break down three pot stocks that I found a lot to like about; mostly their financial track records, momentum, and the fact that experts strongly agree on their buy ratings:
Innovative Industrial Properties Inc (IIPR)
Innovative Industrial Properties Inc (IIPR) is a unique company that focuses on the purchase, ownership, and administration of specialized cannabis properties, which are then leased or sold to experienced, state-licensed operators for their regulated medical-use cannabis operations. Despite being a part of the marijuana market, IIPR is actually a REIT (real estate investment trust) and is taxed as such. It has a presence in over 20 states. PharmaCann, Inc., SH Parent, Inc., Ascend Wellness Holdings, Inc., Cresco Labs Inc., and Kings Garden Inc. are among the cannabis firms in IIPR‘s property portfolio. Alan D. Gold and Paul E. Smithers created IIPR on June 15, 2016, and it is headquartered in Park City, Utah.
IIPR’s success and popularity with economists can be seen through its numbers. We’ll start with IIPR’s last earnings report, as the firm outperformed expectations on EPS by 4.19% and revenue projections by 2.09%. Year-over-year, IIPR shows healthy numbers in crucial areas: Revenue – 44.29%; Net Income – 37.07%; EPS – 21.37; Operating Income – 34.01%. Until IIPR reports again, closer to holiday time, its current quarter indicates $68.5 million in sales, at an EPS of $1.33. IIPR currently has a dividend yield of 6.88%, providing a quarterly payout of $1.75 per share. The consensus 12-month price target for IIPR from the analysts providing annual predictions is 142.50, with a high of 248.00 and a low of 100.00. The median forecast suggests a 40.09% gain from current pricing, and analysts maintain that this buy-rated stock is an ample opportunity.
Green Thumb Industries Inc (GTBIF)
Green Thumb Industries Inc (GTBIF) manufactures, distributes, and sells different cannabis products for medicinal and recreational use in the U.S. Through GTBIF’s Under the Beboe, Doctor Solomon’s, Good Green, Dogwalkers, and RHYTHM brands, GTBIF sells cannabis flower as well as processed and packaged items such as pre-rolls, concentrates, vaporizers, tinctures, candies, other edibles, skin applicants, and other cannabis-related products. GTBIF primarily distributes its products to third-party retail outlets, but it also sells finished items directly to customers through its retail locations. GTBIF owned and managed 77 retail shops in the United States as of April 11, 2022. GTBIF was established in 2014 and is based in Chicago, Illinois.
I was pleasantly surprised during my research on GTBIF when seeing its last earnings report. It surpassed Wall Street’s projections for EPS by a margin of 142.46% — not to leave out a more modest revenue beat of 1.96%. Still, the larger numbers are just more fun. GTBIF‘s quarterly sales of $254.31 million, up 14.62% year over year, were $5.40 million higher than expected by the market. GTBIF shows healthy year-over-year growth: revenue of14.62%, net income of 10.82%; GTBIF has a price target of 21.00, with a high of 38.89 and a low of 11.68 among the analysts who provide yearly price projections. The median prediction is a 91.26% increase from the most recent pricing. GTBIF’s buy rating has been consistent and strong, so much so that the only contention I found was a lone Outperform.
Marimed Inc (MRMD)
MariMed Inc (MRMD) cultivates, manufactures, and distributes medical and recreational cannabis in the U.S. and overseas. MRMD’s Nature’s Heritage brand, while implementing genetics, produces excellent flowers and THC concentrates. MRMD’s Kalm Fusion brand offers cannabis-infused goods in chewable tablets and even drinks, while MRMD’s Betty’s Eddie’s brand offers natural fruit chews. Then there’s the Bubby’s Baked brand, through which MRMD offers sweet-tooth edibles such as brownies and other sweet treats. MRMD also leases cannabis factories and licenses its brands and product formulas. MRMD was founded in 2011 and is headquartered in Norwood, Massachusetts.
MRMD published its financial results for its second fiscal year, 2022, during which $33 million in sales were recorded, an increase of 1.2% over the previous year. On July 18th, MRMD stated that the Maryland Medical Cannabis Commission had permitted the organization to use the enlarged production kitchen at its growing facility in Hagerstown, Maryland. MRMD also announced the launch of new cannabis-infused ice cream, and MRMD created the cannabis-infused vegan and dairy ice cream in partnership with the Boston-based Emack & Bolio’s. MRMD has an average consensus price target of 1.23 from analysts that provide yearly price estimates. The forecast is a 97.58% increase over the previous price, giving it a solid buy rating. Hey, the pot-infused ice cream was only a matter of time, right?
Read Next: America is going mad—is this next?
America is definitely going a little mad…
Some states are threatening to break away. The rich are fleeing. The wealth gap is soaring.
According to a recent article in the New York Times, people are driving more recklessly than ever… and drinking more alcohol than ever too.
And that’s just the beginning…
Altercations on airplanes are now at all-time highs. So are murder rates. And violent crime is soaring across the board. Students are more disruptive than ever. Hate crimes have hit a 12-year high, according to the FBI.
The question of course is:
Where is this all headed… and what’s coming next?
Well, one of the wealthiest and most successful entrepreneurs in America has a very clear answer you’re unlikely to hear anywhere else…
Bill Bonner is a 73-year-old son of a tobacco farmer, who now owns six large properties in South America, Central America, and the U.S… plus three in Europe.
Bonner is also one of the most humble and thoughtful men in the world today. He’s the author of three New York Times bestsellers… and has built several homes with his own hands, using ancient building techniques.
I’m telling you about Bonner today because has just come forward with an important message…
What he calls: His 4th and Final Warning.
It’s worth paying attention to, because Bonner has made 3 other big macro-economic predictions in his career… and each one proved to be exactly right.
Today, Bonner says we are headed towards a very difficult period in the U.S.… one of our most difficult times ever… which will result in something he calls: “America’s Nightmare Winter.”
What does that mean, exactly—and how could it affect you and your money?
Bonner doesn’t claim to have all the answers–but he recently went public with the fascinating analysis, recorded at his 60-acre property overlooking one of Europe’s most beautiful rivers.
He says:
“I believe it falls on someone like me to warn people… clearly… and without distraction.
“I can do this now because I’m too rich to care about money… and too old to care about what anyone says about me.”
And in this analysis, Bonner explains exactly how he believes this difficult period will play out, and even more important: The 4 Steps every American should take right now to prepare.
Get the facts.
Learn how to protect yourself and get a peek inside Bonner’s spectacular European property.
We’ve posted Bonner’s full analysis and his 4 recommended steps on our website.
You can view it free of charge here…
